Search Results for

*

1-5 of 5 ResultsHelp using search on aafp.org Sort by Relevance , Date , Title

Osteoporosis in Men - American Family Physician

Sep 1, 2010 - Osteoporosis is an important and often overlooked problem in men. Although the lifetime risk of hip fracture is lower in men than in women, men are twice as likely to die after a hip fracture. Bone mineral density measurement with a T-score of -2.5 or less indicates osteoporosis. The ...

American Family Physician : Article

https://www.aafp.org/afp/2010/0901/p503.html

Diagnosis and Treatment of Osteoporosis - American Family Physician

Feb 1, 2009 - Osteoporosis affects approximately 8 million women and 2 million men in the United States. The associated fractures are a common and preventable cause of morbidity and mortality in up to 50 percent of older women. The U.S. Preventive Services Task Force recommends using dual energy ...

American Family Physician : Article

https://www.aafp.org/afp/2009/0201/p193.html

Radiologic Bone Assessment in the Evaluation of Osteoporosis - American Family Physician

Apr 1, 2002 - Osteoporosis affects nearly 28 million elderly Americans. Its major clinical manifestation is fragility fractures of the spine, hip, and distal radius. Low bone mass is the most important risk factor for a fragility fracture. In 1994, the World Health Organization defined osteoporosis ...

American Family Physician : Article

https://www.aafp.org/afp/2002/0401/p1357.html

Osteoporosis: Part I. Evaluation and Assessment - American Family Physician

Mar 1, 2001 - Osteoporosis afflicts 75 million persons in the United States, Europe and Japan and results in more than 1.3 million fractures annually in the United States. Because osteoporosis is usually asymptomatic until a fracture occurs, family physicians must identify the appropriate timing and ...

American Family Physician : Article

https://www.aafp.org/afp/2001/0301/p897.html

Raloxifene: A Selective Estrogen Receptor Modulator - American Family Physician

Sep 15, 1999 - Raloxifene is a selective estrogen receptor modulator that produces both estrogen-agonistic effects on bone and lipid metabolism and estrogen-antagonistic effects on uterine endometrium and breast tissue. Because of its tissue selectivity, raloxifene may have fewer side effects than are...

American Family Physician : Article

https://www.aafp.org/afp/1999/0915/p1131.html

Page  1

25 50 100 results per page